Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GLIOMA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
GLIOMA is a concept in neurodegeneration research. Key relationships include: co discussed, regulates, treats. Associated with ALZHEIMER, ALZHEIMER'S, CANCER. Connected to 32 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | GLIOMA |
| Key Genes/Proteins | ACHE, AKT, AMPK, APP, BAX |
| Related Diseases | ALS, ALZHEIMER, ALZHEIMER'S, ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS |
graph TD
GLIOMA["GLIOMA"]
GLIOMA -->|"target for"| Autophagy["Autophagy"]
GLIOMA -->|"regulates"| Cell_Cycle["Cell Cycle"]
GLIOMA -->|"regulates"| Mtor["Mtor"]
GLIOMA -->|"activates"| Complement["Complement"]
GLIOMA -->|"activates"| Mapk["Mapk"]
GLIOMA -->|"target for"| Akt["Akt"]
GLIOMA -->|"target for"| Pi3K["Pi3K"]
pericyte_senescence["pericyte senescence"] -->|"activates"| GLIOMA
CBD["CBD"] -->|"treats"| GLIOMA
TRPV4["TRPV4"] -.biomarker for.-> GLIOMA
doxorubicin["doxorubicin"] -->|"treats"| GLIOMA
mitophagy["mitophagy"] -->|"causes"| GLIOMA
temozolomide["temozolomide"] -->|"treats"| GLIOMA
cannabidiol["cannabidiol"] -->|"treats"| GLIOMA
ATRX["ATRX"] -.biomarker for.-> GLIOMA
BRAF["BRAF"] -.biomarker for.-> GLIOMA
CIC["CIC"] -.biomarker for.-> GLIOMA| Target | Relation | Type | Str |
|---|---|---|---|
| Als | therapeutic_target | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Glioblastoma | associated_with | disease | 0.95 |
| Cancer | therapeutic_target | disease | 0.95 |
| Glioblastoma | activates | disease | 0.95 |
| Neurodegeneration | activates | disease | 0.85 |
| Glioblastoma | therapeutic_target | disease | 0.85 |
| Als | associated_with | disease | 0.85 |
| Stress Granules | associated_with | process | 0.80 |
| Autophagy | activates | pathway | 0.80 |
| Blood-Brain Barrier | therapeutic_target | pathway | 0.80 |
| Apoptosis | activates | pathway | 0.80 |
| Stem Cell | activates | pathway | 0.80 |
| Glioblastoma | regulates | disease | 0.75 |
| Cancer | regulates | disease | 0.75 |
| Cancer | activates | disease | 0.75 |
| Apoptosis | therapeutic_target | pathway | 0.70 |
| Pi3K/Akt | therapeutic_target | pathway | 0.70 |
| Mtor | activates | pathway | 0.70 |
| Tumor Microenvironment | therapeutic_target | pathway | 0.70 |
| Invasion | regulates | pathway | 0.70 |
| Chemoresistance | activates | pathway | 0.70 |
| Stem Cell | therapeutic_target | pathway | 0.70 |
| Ferroptosis | activates | pathway | 0.70 |
| intratumoral heterogeneity | associated_with | process | 0.70 |
| Differentiation | activates | pathway | 0.70 |
| Invasion | activates | pathway | 0.70 |
| Apoptosis | inhibits | pathway | 0.70 |
| Aging | therapeutic_target | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| MACROPHAGE | associated_with | cell_type | 0.65 |
| Mtor | therapeutic_target | pathway | 0.65 |
| TUMOR | associated_with | disease | 0.65 |
| Aging | treats | disease | 0.65 |
| APP | associated_with | gene | 0.65 |
| LACTATE | interacts_with | phenotype | 0.65 |
| MACROPHAGES | associated_with | cell_type | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| T CELL | expressed_in | cell_type | 0.65 |
| STING | reduces | gene | 0.65 |
| MACROPHAGE | mediates | cell_type | 0.65 |
| PI3K | promotes | gene | 0.65 |
| PERICYTE | causes | cell_type | 0.65 |
| PERICYTE | contributes_to | cell_type | 0.65 |
| PI3K | activates | gene | 0.65 |
| Epithelial-Mesenchymal Transition | therapeutic_target | pathway | 0.60 |
| MAPK | causes | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Tumor | activates | disease | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| GLIOBLASTOMA | activates | gene | 1.00 |
| Tumor | associated_with | disease | 1.00 |
| GLIOBLASTOMA | associated_with | gene | 1.00 |
| IDH2 | associated_with | entity | 0.98 |
| IDH1 | associated_with | entity | 0.98 |
| NEURODEGENERATION | activates | gene | 0.95 |
| LOXL1 | associated_with | gene | 0.92 |
| LOXL3 | associated_with | gene | 0.92 |
| LOXL2 | associated_with | gene | 0.92 |
| LOXL4 | associated_with | gene | 0.92 |
| LOX | associated_with | gene | 0.92 |
| 1p/19q Codeletion | biomarker_for | biomarker | 0.90 |
| Claudins | promotes | protein | 0.90 |
| IDH2 | biomarker_for | gene | 0.90 |
| Stress Granules | associated_with | process | 0.90 |
| 1P/19Q Codeletion | biomarker_for | biomarker | 0.90 |
| AUTOPHAGY | activates | gene | 0.85 |
| Berberine-Inspired Ionizable Lipid | treats | compound | 0.85 |
| GBM | activates | gene | 0.85 |
| CANCER | activates | gene | 0.85 |
| EGFR | therapeutic_target | gene | 0.85 |
| LOX | biomarker_for | gene | 0.85 |
| CANCER | regulates | gene | 0.85 |
| Lox/Loxl Co-Expressed Genes | biomarker_for | biomarker | 0.85 |
| GLIOBLASTOMA | therapeutic_target | gene | 0.85 |
| GBM | therapeutic_target | gene | 0.85 |
| MCOLN1 | targets | protein | 0.85 |
| APOPTOSIS | activates | gene | 0.85 |
| GLIOBLASTOMA | regulates | gene | 0.85 |
| PIEZO1 | associated_with | protein | 0.80 |
| Senescence Associated Secretory Phenotype | associated_with | phenotype | 0.80 |
| CLDN1 | downregulates | gene | 0.80 |
| HDAC inhibitors | treats | drug | 0.80 |
| Metal complexes (dicyanoargentate-based) | treats | compound | 0.80 |
| CLDN5 | downregulates | gene | 0.80 |
| senescence | promotes | process | 0.80 |
| Piezo1 | implicated_in | protein | 0.80 |
| LOX/LOXL | targets | enzyme | 0.80 |
| Senescence | contributes_to | process | 0.80 |
| Berberine-inspired Ionizable Lipid | treats | compound | 0.80 |
| COMT | associated_with | gene | 0.80 |
| GSDM Family | biomarker_for | protein | 0.80 |
| RPL39 | biomarker_for | gene | 0.80 |
| Mutation-Specific Antibodies | biomarker_for | biomarker | 0.80 |
| KIF2A | associated_with | gene | 0.80 |
| B-series Gangliosides | associated_with | compound | 0.80 |
| STRESS GRANULES | associated_with | entity | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning GLIOMA in their description or question text
No additional research found